beta-thalassemia gene therapy (Enzene Biosciences)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namebeta-thalassemia gene therapy (Enzene Biosciences)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/Indicationsbeta-Thalassemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEnzene Biosciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnzene Biosciences Ltd
Active IndicationsN/A
Inactive Indicationsbeta-Thalassemia

Other Information

ATC CodeN/A
Related LinksN/A